Background On Dec 31, 2019, China reported a cluster of cases of pneumonia in people at
Wuhan, Hubei Province. The responsible pathogen is a novel coronavirus, named severe …

Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …

Background On 7 February 2020, French Health authorities were informed of a confirmed
case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an Englishman …

Background Neuraminidase inhibitors are thought to be efficacious in reducing the time to
alleviation of symptoms in outpatients with seasonal influenza. The objective of this study was …

… Yahia MEKKI and Maude BOUSCAMBERT DUCHAMP performed viral analyses and contributed
… Yahia MEKKI and Maude BOUSCAMBERT DUCHAMP declare no conflict of interest. …

[3] Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of
103 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25. 104 …

Objectives We evaluated the clinical, virological and safety outcomes of lopinavir/ritonavir,
lopinavir/ritonavir–interferon (IFN)-β-1a, hydroxychloroquine or remdesivir in comparison to …

This short report based on clinical surveillance and laboratory data describes the circulation
of rhinoviruses, influenza viruses and respiratory syncytial viruses (RSV) in France during …

Objectives To determine if commercially available mouthwash with β-cyclodextrin and citrox
(bioflavonoids) (CDCM) could decrease the severe acute respiratory syndrome coronavirus …

Objectives To assess the diagnostic performances of chest CT for triage of patients in
multiple emergency departments during COVID-19 epidemic, in comparison with reverse …